Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 76 AL 90

Gut Microbiota in Alzheimer's Disease and Healthy Aging: Mechanisms, Prevention Strategies and Healthcare Burden

Çeli̇k MN, Mohammadzadeh M, Ahıskalı Öksüz M, Coşkun Us N, Ünlü Söğüt M.

Curr Nutr Rep. 2026 Oct 24;15(1):88. doi: 10.1007/s13668-026-00812-x.

Immunopharmacology of proton pump inhibitors in Alzheimer's Disease: An evidence-weighted mechanistic review of Neuroinflammation, neuroprotection, and neurodegeneration

Alshammari F, M Al-Kuraishy H, M Abdelaziz A, Alruwaili M, Batiha GE.

Int Immunopharmacol. 2026 Oct 26;191(Pt 1):117618. doi: 10.1016/j.intimp.2026.117618. Online ahead of print.

Ozone as a Catalyst for Alzheimer's Disease and Sleep Disorders: Implications for Neurodegeneration Induced by Air Pollution

López-Landa A, González-Sánchez E, Pérez-Villavicencio J, Serrano García N, García-Hernández C, Lee Á, Rubio-Osornio M, Rubio C.

Biology (Basel). 2026 Oct 21;15(20):1904. doi: 10.3390/biology15201904.

Peripheral neuropathy as a presenting feature of familial early onset Alzheimer's disease: a rare clinical association

Seemikeri CC, Mailankody P, Rajeswarie RT, Chanda B, Mahale RR, Padmanabha H.

Acta Neurol Belg. 2026 Oct;126(5):1845-1848. doi: 10.1007/s13760-026-03142-5. Epub 2026 Jul 10.

Alzheimer's disease and olfactory dysfunction: A 20-year systematic bibliometric and genomic analysis

Yang G, Meng C, Zhu D.

J Alzheimers Dis. 2026 Nov;114(1):5-16. doi: 10.1177/13872877261486344. Epub 2026 Oct 7.

Progressive Amyloid-Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier

Stögmann E, Haider L, Leinkauf J, Nakuz T, Untersteiner H, Farr C, Silvaieh S, Parvizi T, Wurm R, Kasprian G, Berger T, Gelpi E, Sieczkowski EB.

Eur J Neurol. 2026 Oct;33(10):e70779. doi: 10.1111/ene.70779.

Intracranial metastasis as a mimic of amyloid-related imaging abnormalities

Hwang J, Delman BN, Naasan G.

Neurol Sci. 2026 Oct 15;47(11):856. doi: 10.1007/s10072-026-09449-8.

Electroencephalography-based Alzheimer's disease detection using multi-scale information retention transform: a subject-level comparison of machine learning classifiers

Zhang P, Tong W, Jiang L, Kan J, Zeng W, Wu B, Zhang H.

Front Neurol. 2026 Sep 30;17:1869211. doi: 10.3389/fneur.2026.1869211. eCollection 2026.

Resilience to mid-to-late-life depression as a risk factor for Alzheimer's disease: Physiological factors and the role of neuroimaging

Chu TDX, Hui LM, Khatri N, Jean Chen J.

Neurobiol Aging. 2026 Oct;166:1-13. doi: 10.1016/j.neurobiolaging.2026.05.004. Epub 2026 May 6.

A working feedback-based framework for goal-directed spatial memory deficits in Alzheimer's disease: Feedforward and feedback interactions along the RSC-MEC-CA1-RSC axis

Tian Y, Qing H, Quan Z.

J Alzheimers Dis. 2026 Oct;113(3):1002-1019. doi: 10.1177/13872877261473933. Epub 2026 Aug 8.

[Memory distortions in Alzheimer's disease and other dementias: an underestimated diagnostic parameter]

Mliavaya T, Hofbauer L, Matthes C, Haussmann R.

Fortschr Neurol Psychiatr. 2026 Oct;94(10):428-433. doi: 10.1055/a-2912-1628. Epub 2026 Aug 18.

The clinical implications of anosognosia in Alzheimer's disease

Moro V, Vianello G, Gambina G, Gobbetto V, Gasparini M, Beccherle M.

Expert Rev Neurother. 2026 Oct;26(10):943-955. doi: 10.1080/14737175.2026.2726416. Epub 2026 Sep 6.

Real-World Patient Eligibility for Alzheimer's Disease Anti-Amyloid Therapy in Seven Swedish Memory Clinics

Rosenberg A, Rennie A, Ekman U, Daniilidou M, Hall A, Matton A, Solomon A, Wahlund LO, Kivipelto M, Westman E.

Eur J Neurol. 2026 Oct;33(10):e70786. doi: 10.1111/ene.70786.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias